BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37084468)

  • 41. Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: The Kuakini Honolulu Heart Program.
    Sanada K; Chen R; Willcox B; Ohara T; Wen A; Takenaka C; Masaki K
    Nutrition; 2018 Feb; 46():97-102. PubMed ID: 29290364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity Definitions in Sarcopenic Obesity: Differences in Prevalence, Agreement and Association with Muscle Function.
    Khor EQ; Lim JP; Tay L; Yeo A; Yew S; Ding YY; Lim WS
    J Frailty Aging; 2020; 9(1):37-43. PubMed ID: 32150212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Body composition assessment for sarcopenic obesity and 3-year mortality in older adults: A comparison study.
    Akgul YSS; Akin S; Cengiz BE; Kocaslan D; Ozer NT
    JPEN J Parenter Enteral Nutr; 2024 May; 48(4):460-468. PubMed ID: 38400558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis.
    Zhang X; Xie X; Dou Q; Liu C; Zhang W; Yang Y; Deng R; Cheng ASK
    BMC Geriatr; 2019 Jul; 19(1):183. PubMed ID: 31269909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.
    Gortan Cappellari G; Semolic A; Zanetti M; Vinci P; Ius M; Guarnieri G; Busetto L; Donini LM; Barazzoni R
    Metabolism; 2023 Aug; 145():155595. PubMed ID: 37245728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
    Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
    Prado CM; Lieffers JR; McCargar LJ; Reiman T; Sawyer MB; Martin L; Baracos VE
    Lancet Oncol; 2008 Jul; 9(7):629-35. PubMed ID: 18539529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of Sarcopenia in Outpatients with Post-Critical SARS-CoV2 Disease. Nutritional Ultrasound of Rectus Femoris Muscle, a Potential Tool.
    Cornejo-Pareja I; Soler-Beunza AG; Vegas-Aguilar IM; Fernández-Jiménez R; Tinahones FJ; García-Almeida JM
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study.
    Sanchez-Rodriguez D; Locquet M; Reginster JY; Cavalier E; Bruyère O; Beaudart C
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1200-1211. PubMed ID: 32657045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma.
    Chargi N; Bril SI; Swartz JE; Wegner I; Willems SM; de Bree R
    Oral Oncol; 2020 Feb; 101():104519. PubMed ID: 31855705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer.
    Matsuo Y; Mitsuyoshi T; Shintani T; Iizuka Y; Mizowaki T
    J Geriatr Oncol; 2018 Nov; 9(6):589-593. PubMed ID: 29779799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004.
    Batsis JA; Mackenzie TA; Lopez-Jimenez F; Bartels SJ
    Nutr Res; 2015 Dec; 35(12):1031-9. PubMed ID: 26472145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Obesity Measures and Definitions of Sarcopenic Obesity in Singaporean Adults - the Yishun Study.
    Pang BWJ; Wee SL; Lau LK; Jabbar KA; Seah WT; Ng DHM; Tan QLL; Chen KK; Jagadish MU; Ng TP
    J Frailty Aging; 2021; 10(3):202-210. PubMed ID: 34105702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
    Baracos VE; Reiman T; Mourtzakis M; Gioulbasanis I; Antoun S
    Am J Clin Nutr; 2010 Apr; 91(4):1133S-1137S. PubMed ID: 20164322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of Age on the Prevalence of Sarcopenic Obesity in Bariatric Surgery Candidates.
    Molero J; Moizé V; Flores L; De Hollanda A; Jiménez A; Vidal J
    Obes Surg; 2020 Jun; 30(6):2158-2164. PubMed ID: 32249368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
    Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sarcopenia and Sarcopenic Obesity and Mortality Among Older People.
    Benz E; Pinel A; Guillet C; Capel F; Pereira B; De Antonio M; Pouget M; Cruz-Jentoft AJ; Eglseer D; Topinkova E; Barazzoni R; Rivadeneira F; Ikram MA; Steur M; Voortman T; Schoufour JD; Weijs PJM; Boirie Y
    JAMA Netw Open; 2024 Mar; 7(3):e243604. PubMed ID: 38526491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of phase angle as a novel indicator for sarcopenic obesity according to the ESPEN/EASO criteria in older adults with diabetes mellitus.
    Hafızoğlu M; Yıldırım HK; Öztürk Y; Şahiner Z; Karaduman D; Atbaş C; Doğu BB; Halil MG; Cankurtaran M; Balcı C
    Nutrition; 2024 Jul; 123():112412. PubMed ID: 38554459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.